Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
2.240
-0.220 (-8.94%)
At close: Apr 28, 2026, 4:00 PM EDT
2.388
+0.148 (6.60%)
After-hours: Apr 28, 2026, 6:38 PM EDT
Lantern Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 6.46 | 6.09 | 5.98 | 5.83 | 5.02 | |
| Research & Development | 11.51 | 16.13 | 11.89 | 8.6 | 6.57 | |
| Operating Expenses | 17.98 | 22.22 | 17.88 | 14.43 | 11.59 | |
| Operating Income | -17.98 | -22.22 | -17.88 | -14.43 | -11.59 | |
| Interest & Investment Income | 0.44 | 0.74 | 0.77 | 0.2 | 0.07 | |
| Other Non Operating Income (Expenses) | 0.38 | 0.54 | 1.15 | -0.03 | 0.05 | |
| EBT Excluding Unusual Items | -17.16 | -20.94 | -15.96 | -14.26 | -11.47 | |
| Gain (Loss) on Sale of Investments | 0.04 | 0.16 | - | - | - | |
| Other Unusual Items | - | - | - | - | -0.89 | |
| Pretax Income | -17.12 | -20.78 | -15.96 | -14.26 | -12.36 | |
| Net Income | -17.12 | -20.78 | -15.96 | -14.26 | -12.36 | |
| Net Income to Common | -17.12 | -20.78 | -15.96 | -14.26 | -12.36 | |
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | |
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | |
| Shares Change (YoY) | 1.26% | -0.74% | -0.08% | -0.50% | 153.31% | |
| EPS (Basic) | -1.57 | -1.93 | -1.47 | -1.31 | -1.13 | |
| EPS (Diluted) | -1.57 | -1.93 | -1.47 | -1.31 | -1.13 | |
| Free Cash Flow | -15.68 | -17.83 | -14.37 | -12.8 | -10.61 | |
| Free Cash Flow Per Share | -1.44 | -1.66 | -1.32 | -1.18 | -0.97 | |
| EBITDA | -17.96 | -22.2 | -17.86 | -14.42 | -11.58 | |
| D&A For EBITDA | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |
| EBIT | -17.98 | -22.22 | -17.88 | -14.43 | -11.59 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.